Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Marcel, Nkuize"'
Publikováno v:
Microorganisms, Vol 11, Iss 4, p 887 (2023)
Objective: Helicobacter pylori and human immunodeficiency virus (HIV) are both pandemic infections with variable geographic prevalence rates. H. pylori–HIV co-infection at the regional and sub-regional levels with a perspective on gastric cancer in
Externí odkaz:
https://doaj.org/article/442b52a59097464eacc932db1e6ec0bf
Autor:
Marcel Nkuize, Jean Vanderpas, Michel Buset, Maria Gomez‐Galdon, Marc Delforge, Véronique Yvette Miendje‐Deyi, Vinciane Muls, Stéphane De Wit
Publikováno v:
MicrobiologyOpen, Vol 10, Iss 3, Pp n/a-n/a (2021)
Abstract The antimicrobial susceptibility of Helicobacter pylori strains isolated from HIV‐positive individuals is not well characterized. This study aimed to measure the prevalence and long‐term trends associated with primary H. pylori antibioti
Externí odkaz:
https://doaj.org/article/b6d3bcbd56d04991811c5ec60619f60d
Autor:
Marcel Nkuize, Stéphane De Wit
Publikováno v:
Microorganisms, Vol 10, Iss 8, p 1541 (2022)
Treatment of Helicobacter pylori infection in people living with HIV is associated with several challenges, including those related to drug metabolism which plays a major role in treatment efficacy. In this review, we will discuss the enzymes involve
Externí odkaz:
https://doaj.org/article/7452175b039e475aa7b99c0f1560395a
Autor:
Veronique Yvette Miendje Deyi, Ruffin Ntounda, Hubert Louis, Nsimire L. Kahegeshe, Marcel Nkuize, Alain Burette, Kalliroy Kotilea, Marc Van Gossum, Myriam Delhaye, Patrick Bontems
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 105:115855
This manuscript summarizes current primary resistance of Helicobacter pylori to antibiotics in Brussels in 2021. Resistance rates were estimated at 18% for clarithromycin, 24% for levofloxacin, 52% for metronidazole, and 0% for amoxicillin and tetrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b11cc6bac2422ac5423a355ce2e62c0e
https://doi.org/10.1016/j.diagmicrobio.2022.115855
https://doi.org/10.1016/j.diagmicrobio.2022.115855
Autor:
Marcel Nkuize, Stéphane De Wit, Vinciane Muls, Marc Delforge, Véronique Y Miendje Deyi, Guy B Cadière, Michel Buset
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145119 (2015)
BACKGROUND:Patients infected with human immunodeficiency virus (HIV) are living longer due to the availability of more potent treatments. However, prescription of antibiotics to treat or prevent infections in these patients may increase the likelihoo
Externí odkaz:
https://doaj.org/article/6f613604ca7841a084736f82e939a706
Autor:
Maria Gomez-Galdon, Veronique Yvette Miendje-Deyi, Vinciane Muls, Jean Vanderpas, Michel Buset, Stéphane De Wit, Marc Delforge, Marcel Nkuize
Publikováno v:
MicrobiologyOpen, Vol 10, Iss 3, Pp n/a-n/a (2021)
MicrobiologyOpen
MicrobiologyOpen
The antimicrobial susceptibility of Helicobacter pylori strains isolated from HIV‐positive individuals is not well characterized. This study aimed to measure the prevalence and long‐term trends associated with primary H. pylori antibiotic resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc8a6b46e0e8e2196f5aca4c6cc1df23
https://pubmed.ncbi.nlm.nih.gov/34180600
https://pubmed.ncbi.nlm.nih.gov/34180600
Publikováno v:
HIV medicineReferences. 22(7)
OBJECTIVES Helicobacter pylori is a worldwide infection, but little is known about the efficacy of treatment for H. pylori infection in HIV-positive patients. The goal of this work was to evaluate outcomes after first-line H. pylori treatment and ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e33add1bb57a8f29ebbf1bfd20912be
https://pubmed.ncbi.nlm.nih.gov/33765332
https://pubmed.ncbi.nlm.nih.gov/33765332
Autor:
Charelle Salem, Carmen Musala, Gertjan André Rasschaert, Pierre Eisendrath, Marcel Nkuize, Léo Duez
Publikováno v:
ESGE Days.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7988bcf4a24eb76eaa914a33b3cfc7c1
https://doi.org/10.1055/s-0040-1704560
https://doi.org/10.1055/s-0040-1704560
Autor:
Nathalie Willems, Stéphane DeWit, Francesco Feoli, Marcel Nkuize, Agnès Libois, Marc Delforge
Publikováno v:
Acta Clinica Belgica. 72:29-35
Over the last few decades, incidence of anal cancer among HIV-positive men has been on the rise. In this context, programmes of screening and treatment of anal dysplasia which is a precursor of anal cancer have been developed. The aim of our study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2161b5145fee26e8e0aca9971ee9500
https://doi.org/10.1080/17843286.2015.1116725
https://doi.org/10.1080/17843286.2015.1116725
Publikováno v:
Therapeutics and Clinical Risk Management
Therapeutics and clinical risk management, 12
Therapeutics and clinical risk management, 12
Chronic hepatitis C treatment has continued to evolve, and interferon-free, oral treatment with direct-acting antiviral agents is the current standard of care. Recently, a new treatment, which is a combination of two direct-acting antiviral agents, l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9caa448a7470ecd369426db6f33b6c62
http://europepmc.org/articles/PMC4902143
http://europepmc.org/articles/PMC4902143